We are live on
!
Find out more
CTA
Carillon Tower Advisers Portfolio holdings
AUM
$16.4B
1-Year Est. Return
64.75%
This Fund
S&P 500
This Quarter
Est. Return
-16.26%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11.8B
AUM Growth
-$2.13B
(-15%)
Cap. Flow
+$457M
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
9.66%
Holding
494
New
75
Increased
149
Reduced
153
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$102M |
| 2 |
AGNC Investment
AGNC
|
+$72.1M |
| 3 |
Mid-America Apartment Communities
MAA
|
+$67.5M |
| 4 |
Constellation Brands
STZ
|
+$66.9M |
| 5 |
Diamondback Energy
FANG
|
+$57.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NTRI
NutriSystem, Inc.
NTRI
|
+$72.5M |
| 2 |
Texas Capital Bancshares
TCBI
|
+$61.7M |
| 3 |
Electronic Arts
EA
|
+$48.9M |
| 4 |
Western Alliance Bancorporation
WAL
|
+$47.2M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.05% |
| 2 | Technology | 17.64% |
| 3 | Industrials | 14.71% |
| 4 | Consumer Discretionary | 13.8% |
| 5 | Financials | 8.63% |
Similar funds
GAM
CCI
SWM
LCM
HCMNY
BII
HCM
DBC
Carillon Tower Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, Carillon Tower Advisers held 494 positions worth $11.8B, down 15% from $13.9B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Carillon Tower Advisers deployed $457M of net new capital in Q4 2018, opening 75 new positions and adding to 149 existing holdings. Its largest new stake was AGNC Investment: 4,047,600 shares worth $71M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Abiomed Inc, an estimated $46M trimmed.
- Carillon Tower Advisers's largest Q4 2018 buy was AGNC Investment: 4,047,600 shares worth $71M.
- Carillon Tower Advisers added most to Centene in Q4 2018, an estimated $102M increase.
- Carillon Tower Advisers's biggest Q4 2018 reduction was Abiomed Inc, cutting an estimated $46M.
- Carillon Tower Advisers fully exited NutriSystem, Inc. in Q4 2018, selling an estimated $72.5M.
- Carillon Tower Advisers's ten largest holdings make up 9.7% of its $11.8B portfolio in Q4 2018.
- Carillon Tower Advisers opened 75 new positions and closed 37 in Q4 2018.
- Carillon Tower Advisers's portfolio value fell 15% quarter-over-quarter to $11.8B.
Based on Carillon Tower Advisers's 13F filing for Q4 2018, filed 13 Feb 2019.